Navigation Links
Isis Reports Financial Results and Highlights for First Quarter 2012
Date:5/8/2012

60; Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs, including the planned commercialization of KYNAMRO, is a forward-looking statement and should be considered an at-risk statement.  Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such drugs.  Isis' forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements.  Although Isis' forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Isis.  As a result, you are cautioned not to rely on these forward-looking statements.  These and other risks concerning Isis' programs are described in additional detail in Isis' annual report on Form 10-K for the year ended December 31, 2011, which is on file with the SEC. Copies of this and other documents are available from the Company.

In this press release, unless the context requires otherwise, "Isis," "Company," "we," "our," and "us" refers to Isis Pharmaceuticals and its subsidiaries, including Regulus Therapeutics Inc., its jointly owned subsidiary.

Isis Pharmaceuticals® is a registered trademark of Isis Pharmaceuticals, Inc.  Regulus Therapeutics™ is a trademark of Regulus Therapeutics Inc.  KYNAMRO™ is a trademark of Genzyme Corporation.ISIS PHARMACEUTICALS, INC.SELECTED FINANCIAL INFORMATIONCondensed Consolidated Statements of Operations(In Thousands, Except Per Share Data)Three months ended,March 31,20122011Revenue:(unaudited)Research and development revenueunder collaborative agreements$21,818
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Vanda Pharmaceuticals Reports First Quarter 2012 Results
2. Landauer, Inc. Reports Fiscal 2012 Second Quarter Results
3. Halozyme Reports First Quarter 2012 Financial Results
4. MAP Pharmaceuticals Reports First Quarter of 2012 Financial Results
5. Anthera Pharmaceuticals Reports 2012 First Quarter Financial Results And Provides Clinical Progress Update
6. IRIDEX Reports 2012 First Quarter Results
7. Cambrex Reports First Quarter 2012 Results
8. Cadence Pharmaceuticals Reports First Quarter 2012 Financial Results
9. Cumberland Pharmaceuticals Reports First Quarter 2012 Financial Results
10. Sequenom, Inc. Reports Financial Results For The First Quarter Of 2012
11. Neuland Labs Reports Financial Results For Fiscal Year 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 2015   Cynosure, Inc. (Nasdaq: ... devices for aesthetic procedures and precision surgical applications ... months ended June 30, 2015. "Our ... growth, as revenues increased 47 percent year-over-year and ... Officer Michael Davin. "While our international results reflected ...
(Date:7/28/2015)... CRY ), a leading medical device and tissue ... today its results for the second quarter and first ... Chairman, President and Chief Executive Officer, said, "During the ... with solid progress on several of our top organizational ... a direct sales model in France, advancing our strategic ...
(Date:7/28/2015)... July 28, 2015 ANI Pharmaceuticals, Inc. (NASDAQ: ... to release its second quarter and year-to-date 2015 financial ... of the U.S. financial markets. The earnings press release ... the Company,s website, www.anipharmaceuticals.com . ... and Charlotte C. Arnold , Vice President and ...
Breaking Medicine Technology:Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 2Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 3Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 4Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 5Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 6Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 7Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 8Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 9Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 10Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 11Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 12Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 13CryoLife Reports Second Quarter Financial Results 2CryoLife Reports Second Quarter Financial Results 3CryoLife Reports Second Quarter Financial Results 4CryoLife Reports Second Quarter Financial Results 5CryoLife Reports Second Quarter Financial Results 6CryoLife Reports Second Quarter Financial Results 7CryoLife Reports Second Quarter Financial Results 8CryoLife Reports Second Quarter Financial Results 9CryoLife Reports Second Quarter Financial Results 10CryoLife Reports Second Quarter Financial Results 11CryoLife Reports Second Quarter Financial Results 12CryoLife Reports Second Quarter Financial Results 13CryoLife Reports Second Quarter Financial Results 14ANI Pharmaceuticals Schedules Conference Call for Second Quarter and Year-to-Date 2015 Financial Results 2
... Mind Technologies, Inc . ( http://mindtechnologiesinc.com ) (Pink Sheets: ... on The Company,s proprietary EEG/ BCI headset, which is ... the world leader in EEG/ BCI technology, Mind Technologies ... process of developing a state-of-the-art headset that would revolutionize ...
... Awarepoint Corporation , the leading ... announced that the U.S. Patent and Trademark Office has ... interaction-based tracking system that helps hospitals enhance their patient ... outcomes. (Logo:   http://photos.prnewswire.com/prnh/20100127/LA44915LOGO ) ...
Cached Medicine Technology:Mind Technologies Inc. Developing Revolutionary EEG Brain Computer Interface 2Awarepoint Awarded U.S. Patent for its Revolutionary Tag-to-Tag Communication Technology 2
(Date:7/28/2015)... , ... July 28, 2015 , ... Please join us for the 5th Annual ... Town Center located at Gary Avenue and Lies Road in Carol Stream. All are welcome. ... raise awareness, and provide education and help to support individuals and families affected by a ...
(Date:7/28/2015)... ... July 28, 2015 , ... One ... including Runner’s World Magazine, is plantar fasciitis . Zensah, the Miami-based compression ... Designed by a professional athletic trainer, the Zensah Ankle Support’s primary benefits include ...
(Date:7/28/2015)... ... July 28, 2015 , ... Intellitec Solutions has been ... annual ranking of Value Added Resellers of ERP Software is a look at the ... with. This honor represents the second such award in 2015 for Intellitec Solutions, following ...
(Date:7/28/2015)... Louis, MO (PRWEB) , ... July 28, 2015 , ... ... back pain comes in as a close second. Clients suffering from headaches and back ... clients get started with chiropractic treatment, The Joint 's nine offices in the ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... ... the post surgical spine patient with discussion and demonstration of specific rehabilitation exercises ... Gain insight into the actual surgical process with an extensive interview conducted by ...
Breaking Medicine News(10 mins):Health News:5th Annual Step for Hope 5K Run/Walk Event in Carol Stream, IL to Benefit Renowned Brain Aneurysm Foundation 2Health News:Zensah Releases Compression Sleeve To Relieve Ankle Pain and Plantar Fasciitis 2Health News:Intellitec Solutions Named by Accounting Today as Top 100 Value Added Reseller 2Health News:The Joint St. Louis Offers “2 for Thursday” Special, Chiropractic Care Services, Affordable Back Pain Relief 2Health News:North American Seminars Introduces a New OT PT PTA Online Continuing Education Course on the Treatment of Post Surgical Cervical and Lumbar Spine Patients 2Health News:North American Seminars Introduces a New OT PT PTA Online Continuing Education Course on the Treatment of Post Surgical Cervical and Lumbar Spine Patients 3Health News:North American Seminars Introduces a New OT PT PTA Online Continuing Education Course on the Treatment of Post Surgical Cervical and Lumbar Spine Patients 4Health News:North American Seminars Introduces a New OT PT PTA Online Continuing Education Course on the Treatment of Post Surgical Cervical and Lumbar Spine Patients 5Health News:North American Seminars Introduces a New OT PT PTA Online Continuing Education Course on the Treatment of Post Surgical Cervical and Lumbar Spine Patients 6
... COLUMBUS, Ohio, Jan. 19 Abbott ... voluntary recall of,ZonePerfect(R) Chocolate Peanut Butter bars, ZonePerfect(R) ... in response to the widening,recall involving peanut butter ... America (PCA). PCA was one of the ...
... with early-stage lung cancer are not seen when patients ... the January issue of Archives of Surgery , ... more deaths in the United States than any other ... resectionor surgery to remove a portion of the lungprovides ...
... setting, study finds , , MONDAY, Jan. 19 (HealthDay News) ... on the rise among American children, a new report ... the bacteria Staphylococcus aureus -- referred to ... methicillin -- are moving beyond the traditional confines of ...
... /PRNewswire-FirstCall/ - The Board of Directors of NUCRYST ... B. Holtz as interim President and Chief Executive ... Chairman, effective immediately. Mr. Holtz replaces Thomas E. ... Officer. Mr. Carragher, currently lead director of NUCRYST, ...
... Aribex, Inc., a world leader in handheld x-ray ... second U.S. patent for its NOMAD Handheld X-ray System. ... concept of having all components of the x-ray system ... development of the world,s first handheld x-ray system. Aribex ...
... ethnicity, types of seafood consumed , , MONDAY, Jan. 19 (HealthDay ... for a living, and her ethnicity may all be ... new survey says. , The report, published in the January ... in coastal areas in the Northeastern United States had ...
Cached Medicine News:Health News:Abbott Nutrition Announces Voluntary Recall of ZonePerfect(R) Chocolate Peanut Butter Bars, ZonePerfect(R) Peanut Toffee Bars and NutriPals(TM) Peanut Butter Chocolate Bars in U.S., Mexico, New Zealand and Singapore 2Health News:Study examines racial disparities in survival among patients diagnosed with lung cancer 2Health News:MRSA Infections Spreading to Kids in Community 2Health News:MRSA Infections Spreading to Kids in Community 3Health News:NUCRYST appoints interim CEO 2Health News:NUCRYST appoints interim CEO 3Health News:Aribex(R) Awarded Patents for Handheld X-ray 2Health News:Women in Coastal Areas Have Higher Mercury Levels 2
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
The ENDO MINI-RETRACT™ 5 mm instrument has application in a variety of gynecologic, abdominal, urologic, thoracic and endoscopic procedures for temporary retraction of tissue and small tubular ...
... Products are kept in ... are offered as 1-piece ... or extra long lengths. ... insulation, flush ports, rotating ...
Medicine Products: